|
Medical News -
Eye Health
|
|
IOPtima, a subsidiary of Bio-Light (TASE:BOLT), the developer of an innovative laser-based surgical device for reducing intra ocular pressure (IOP) for the treatment of glaucoma, successfully completed and analyzed the results of its first 12-month follow-up period of human clinical trials conducted in Mexico and India. IOPtima's novel, laser-based technology enables eye surgeons to perform a simple and safe surgery and reduce IOP without penetrating the eye membrane. Read more:
|
